Suppr超能文献

分化型甲状腺癌患者术后放射性碘治疗对甲状旁腺功能的长期影响。

Long-term effect of postoperative radioactive iodine therapy on parathyroid function in patients with differentiated thyroid cancer.

作者信息

Avcı Merdin Fatma, Gökçay Canpolat Asena, Çorapçıoğlu Demet, Soydal Çiğdem, Şahin Mustafa

机构信息

Department of Endocrinology and Metabolism, Ankara University School of Medicine, Ankara, Türkiye.

Department of Nuclear Medicine, Ankara University School of Medicine, Ankara, Türkiye.

出版信息

Ann Nucl Med. 2025 Mar;39(3):278-284. doi: 10.1007/s12149-024-01996-4. Epub 2024 Nov 4.

Abstract

OBJECTIVE

The study aimed to assess the impact of postoperative radioactive iodine (RAI) therapy on parathyroid function in patients who underwent total or subtotal thyroidectomy for differentiated thyroid cancer (DTC).

METHODS

Data from 150 patients treated with RAI for DTC and 76 patients with low-risk DTC not receiving RAI were retrospectively analyzed. Clinical characteristics, preoperative and 1-month postoperative biochemical parameters, and adjusted calcium, phosphorus, parathyroid hormone (PTH), and 25-hydroxyvitamin D3 (25-OH-D) levels at 3 months, 1 year, 3 years, and 5 years post-RAI (or in the low-risk group) were recorded.

RESULTS

A total of 226 DTC patients were included in the study (80.5% female, mean age 42.7 ± 13.2 years). Total thyroidectomy was performed in 97.3% (n = 220) of patients, with central lymph node dissection (CLND) in 41.6% (n = 94). No significant preoperative differences in PTH, aCa, P, Mg, or 25-hydroxyvitamin D3 levels were observed. However, patients receiving ≥ 3.7 GBq (or 100 mCi) RAI (n = 70) had lower calcium and PTH levels at the end of the first year following RAI treatment (p = 0.048, p = 0.032). The non-RAI group showed significantly higher calcium levels at one month postoperatively (p = 0.031) and lower rates of CLND and neck dissection. No significant differences in biochemical parameters were found at the five-year follow-up, except for one patient who developed normocalcemic hyperparathyroidism after RAI.

CONCLUSION

High-dose RAI therapy may lead to transient decreases in calcium and PTH levels in the early post-treatment period. However, long-term parathyroid function appears to remain unaffected in DTC patients, regardless of the RAI dose administered. Nonetheless, close monitoring of calcium and PTH levels is recommended, particularly in the early post-treatment period, to promptly manage any potential transient hypoparathyroidism.

摘要

目的

本研究旨在评估术后放射性碘(RAI)治疗对因分化型甲状腺癌(DTC)接受全甲状腺切除术或次全甲状腺切除术患者甲状旁腺功能的影响。

方法

回顾性分析150例接受RAI治疗的DTC患者及76例未接受RAI治疗的低风险DTC患者的数据。记录临床特征、术前及术后1个月的生化参数,以及RAI治疗后3个月、1年、3年和5年(或低风险组)的校正钙、磷、甲状旁腺激素(PTH)和25-羟维生素D3(25-OH-D)水平。

结果

本研究共纳入226例DTC患者(女性占80.5%,平均年龄42.7±13.2岁)。97.3%(n=220)的患者接受了全甲状腺切除术,41.6%(n=94)的患者进行了中央区淋巴结清扫(CLND)。术前PTH、校正钙、磷、镁或25-羟维生素D3水平无显著差异。然而,接受≥3.7GBq(或100mCi)RAI治疗的患者(n=70)在RAI治疗后第1年末钙和PTH水平较低(p=0.048,p=0.032)。非RAI组术后1个月钙水平显著较高(p=0.031),CLND和颈部清扫率较低。除1例患者在RAI治疗后发生血钙正常的甲状旁腺功能亢进外,5年随访时生化参数无显著差异。

结论

高剂量RAI治疗可能导致治疗后早期钙和PTH水平短暂下降。然而,无论给予何种RAI剂量,DTC患者的长期甲状旁腺功能似乎不受影响。尽管如此,建议密切监测钙和PTH水平,尤其是在治疗后早期,以便及时处理任何潜在的短暂性甲状旁腺功能减退。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验